Position
Scientech Research LLC in Maxcyte, Inc.
Back to the book · All holders of MXCT
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$10.7K$1.55 → $0.70
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 12.6K | $19.6K | — | — | — | 0.0% |
| Q1 2026 | 12.6K | $8.84K | $0.70 | −$10.7K | −$88 | 0.0% |